BAAT Score for Septal Fibrosis in Overweight Patient

Purpose: To identify an overweight patient who is at risk for septal fibrosis in a liver biopsy using the BAAT scoreof Ratzui et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating an overweight patient with unexplained elevations in liver functon tests?

Yes

Age of the patient

years

Body weight

Body height

Serum triglyceride concentration

Serum ALT

Upper limit of the normal reference range for ALT

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Body mass index

Ratio of serum ALT to the upper limit of normal

Total BAAT score

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Laboratory Tests
Other Testing
- Grading and Staging Scheme for Nonalcoholic Steatohepatitis
- Pediatric Non Alcoholic Fatty Liver Disease (NAFLD)
Criteria For Diagnosis
- NAFLD Fibrosis Score
Severity, Prognosis, Stage
Complications
- Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatic Fibrosis
Differential Diagnosis And Mimics, Red Flags
- Model for Distinguishing Nonalcoholic Steatohepatitis (NASH) from Cryptogenic Chronic Hepatitis

Therapy

Options
- Predictors of Angulo et al for Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
Prevention
- Predictors of Angulo et al for Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis

Monitoring

Disease Progression
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score (NAS) of Kleiner et al
- Modified Criteria for Histologic Scoring of Nonalcoholic Steatohepatitis
Complication Detection
- Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatic Fibrosis

Specialty

Gastroenterology
Nutrition

Objective

severity
prognosis
stage

ICD-10

E66 - Obesity

Info

Purpose: To identify an overweight patient who is at risk for septal fibrosis in a liver biopsy using the BAAT scoreof Ratzui et al.

Specialty: Gastroenterology, Nutrition

Objective: severity, prognosis, stage

ICD-10: E66,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path